TAIWAN · TWSE / TPEx
WINSTON
溫士頓 · 6817 · Emerging Stock Board · Biotech and medical
Share price, 2026-10-19NT$43.101 month +2.4% · 1 year -58.4%
Directors and supervisors hold10,379,88356.4% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold10,110,40054.9% of shares issued
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 蔡森田 | Chairman | — | 0 | — | — | — |
| 基亞生物科技股份有限公司 | Director · Major shareholder (10%+) | 10,110,400 | 10,110,400 | 54.90% | — | — |
| 江雅鈴 | Director (corporate representative) | — | 40,000 | 0.22% | — | — |
| 王又正 | Director · President · Other | 269,483 | 269,483 | 1.46% | — | — |
| 張世忠 | Director (corporate representative) | — | 0 | — | — | — |
| 劉曉峻 | Independent director | — | 0 | — | — | — |
| 林世勳 | Independent director | — | 0 | — | — | — |
| 王耀賢 | Independent director | — | 0 | — | — | — |
| 陳怡菁 | Vice president | — | 120,000 | 0.65% | — | — |
| 蘇文宗 | Assistant vice president | — | 20,000 | 0.11% | — | — |
| 張馨文 | Chief financial officer · Chief accountant · Other | — | 0 | — | — | — |